🔗 Permalink

Inventor profile of:

Thomas M. Lancaster

City:

Stoneham, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2018-03-08

Top Assignees for applications by Thomas M. Lancaster

The entities that hold a legal rights for patent applications filed by inventor Lancaster Thomas M.:

SmartCells, Inc. 8 Whitehouse Station, NJ United States
SMARTCELLS, INC. 6 Kenilworth, NJ United States
SMARTCELLS, INC. 5 Beverly, MA United States
Smartcells, Inc. 2 Rahway, NJ United States
The United States of America Dept. of Health and Human Services (DHHS) 1 Washington, DC United States
Merck Sharp Dohme Corp. 1 Rahway, NJ United States
Smart Cells, Inc. 1 Kenilworth, NJ United States
Smartcells 1 Beverly, MA United States
SmartCells, Inc. 1 Berverly, MA United States
Merck 1 P.O. BOX 2000, NJ United States
The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) 1 Washington, DC United States
SMART CELLS, INC. 1 Whitehouse Station, NJ United States
National Institutes of Health (NIH) 1 Bethesda, MD United States

Recent patent applications by Lancaster Thomas M.

Thomas M. Lancaster from Stoneham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-03-08

US20180064824A1

Human necessities

Conjugate based systems for controlled drug delivery

#2 | 2017-01-26

US20170022262A1

Chemistry; metallurgy

CRYSTALLINE INSULIN-CONJUGATES

#3 | 2016-07-07

US20160193351A1

Human necessities

CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY

#4 | 2015-09-24

US20150265717A1

Human necessities

Conjugate based systems for controlled drug delivery

#5 | 2014-11-20

US20140342980A1

Chemistry; metallurgy

Binding-site modified lectins and uses thereof

#6 | 2014-09-18

US20140275476A1

Human necessities

Crystalline insulin-conjugates

#7 | 2014-09-18

US20140274888A1

Human necessities

Conjugate based systems for controlled drug delivery

#8 | 2014-09-11

US20140256622A1

Human necessities

Exogenously triggered controlled release materials and uses thereof

#9 | 2014-05-01

US20140121159A1

Human necessities

Terminally-functionalized conjugates and uses thereof

#10 | 2014-02-06

US20140037699A1

Chemistry; metallurgy

SOLUBLE NON-DEPOT INSULIN CONJUGATES AND USES THEREOF

#11 | 2013-12-05

US20130324702A1

Chemistry; metallurgy

Recombinant lectins, binding-site modified lectins and uses thereof

#12 | 2013-11-14

US20130302825A1

Physics

USES OF MACROPHAGE MANNOSE RECEPTOR TO SCREEN COMPOUNDS AND USES OF THESE COMPOUNDS

#13 | 2013-07-25

US20130190476A1

Chemistry; metallurgy

Recombinantly expressed insulin polypeptides and uses thereof

#14 | 2013-07-25

US20130190475A1

Human necessities

Drug-ligand conjugates, synthesis thereof, and intermediates thereto

#15 | 2013-05-23

US20130131310A1

Chemistry; metallurgy

DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO

#16 | 2012-05-31

US20120135919A1

Chemistry; metallurgy

Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator

#17 | 2012-02-23

US20120046223A1

Human necessities

Exogenously triggered controlled release materials and uses thereof

#18 | 2012-01-19

US20120014908A1

Human necessities

Terminally-functionalized conjugates and uses thereof

#19 | 2012-01-12

US20120010134A1

Chemistry; metallurgy

Soluble non-depot insulin conjugates and uses thereof

#20 | 2011-12-08

US20110301083A1

Human necessities

Conjugate based systems for controlled drug delivery

#21 | 2011-11-17

US20110281939A1

Chemistry; metallurgy

Polynucleotide aptamer-based cross-linked materials and uses thereof

#22 | 2011-11-17

US20110281792A1

Chemistry; metallurgy

BINDING-SITE MODIFIED LECTINS AND USES THEREOF

#23 | 2011-11-17

US20110281791A1

Chemistry; metallurgy

Crystalline insulin-conjugates

#24 | 2011-11-10

US20110275560A1

Human necessities

Synthetic conjugates and uses thereof

#25 | 2010-05-27

US20100130726A1

Chemistry; metallurgy

Methods for reducing the mitogenicity of lectin compositions

#26 | 2007-05-17

US20070110811A1

Chemistry; metallurgy

Methods for reducing the mitogenicity of lectin compositions

#27 | 2007-05-03

US20070099820A1

Chemistry; metallurgy

Polymer-drug conjugates

InventorID:

264386 ⎘